I agree that this site is using cookies. You can find further informations here.
X
Deeren, D.
187  results:
Search for persons X
?
1

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:

Dezern, A. ; Fenaux, P. ; Deeren, D....
Leukemia Research.  128 (2023)  - p. 107269 , 2023
Link: https://doi.org/10.1016/..
 
?
2

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY D..:

Chamuleau, M. ; Stenner, F. ; Chitu, D....
Hematological Oncology.  41 (2023)  S2 - p. 50-51 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Addition of the nuclear export inhibitor selinexor to stand..:

Janssen, J. J. W. M. ; Löwenberg, B. ; Manz, M....
Leukemia.  36 (2022)  9 - p. 2189-2195 , 2022
Link: https://doi.org/10.1038/..
 
?
4

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBA..:

DeZern, A. ; Marconi, G. ; Deeren, D....
HemaSphere.  6 (2022)  - p. 1800-1801 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P699: REAL-LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS..:

Devos, T. ; Havelange, V. ; Theunissen, K....
HemaSphere.  6 (2022)  - p. 594-595 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STU..:

Dimopoulos, M.-A. ; Amaador, K. ; Minnema, M. C....
HemaSphere.  6 (2022)  - p. 995-996 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THER..:

Rijneveld, A. ; Gradowska, P. ; Bellido, M....
HemaSphere.  6 (2022)  - p. 266-267 , 2022
Link: https://doi.org/10.1097/..
 
?
8

Lenalidomide added to standard intensive treatment for olde..:

Ossenkoppele, G. J. ; Breems, D. A. ; Stuessi, G....
Leukemia.  34 (2020)  7 - p. 1751-1759 , 2020
Link: https://doi.org/10.1038/..
 
?
9

Correction: Lenalidomide added to standard intensive treatm..:

Ossenkoppele, G. J. ; Breems, D. A. ; Stuessi, G....
Leukemia.  34 (2020)  10 - p. 2820-2820 , 2020
Link: https://doi.org/10.1038/..
 
?
10

PCN39 TREATMENT PATTERNS, MINIMAL RESIDUAL DISEASE (MRD) TE..:

Spyridonidis, A. ; Deeren, D. ; Bouwmeester, W....
Value in Health.  22 (2019)  - p. S442-S443 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Evaluation of health and quality of life in apheresis patie..:

Goto, J. ; Newman, E. ; Witt, V....
Transfusion and Apheresis Science.  58 (2019)  5 - p. 641-644 , 2019
Link: https://doi.org/10.1016/..
 
?
12

The interaction of factor V and tissue factor pathway inhib..:

De Maertelaere, E. ; Castoldi, E. ; Van haute, I...
Haemophilia.  24 (2018)  3 - p. , 2018
Link: https://doi.org/10.1111/..
 
?
13

REMARC STUDY: CORRELATION OF LYMPHOMA PD AND DEATH AND HEAL..:

Thieblemont, C. ; Casasnovas, R. ; Mounier, N....
Hematological Oncology.  35 (2017)  S2 - p. 102-103 , 2017
Link: https://doi.org/10.1002/..
 
?
14

Distribution of indications and procedures within the frame..:

Stegmayr, B. ; Mörtzell Henriksson, M. ; Newman, E....
Transfusion and Apheresis Science.  56 (2017)  1 - p. 71-74 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Adverse events in apheresis: An update of the WAA registry ..:

Mörtzell Henriksson, M. ; Newman, E. ; Witt, V....
Transfusion and Apheresis Science.  54 (2016)  1 - p. 2-15 , 2016
Link: https://doi.org/10.1016/..
 
1-15